| Document Date: 2014-01-07 12:50:14
Open Document File Size: 293,79 KBShare Result on Facebook
City Patkar / Victoria / / Company Dell / References 1 Saag KG. / CCP / BC Biomedical Laboratories Ltd. / Rheumatoid Arthritis Resources / / Country New Zealand / / / Facility Best Practice Advocacy Centre / American College of Rheumatology / / IndustryTerm healthcare / treatment of RA disease / treatment of dyslipidemia and prevention of cardiovascular disease / / MedicalCondition Rheumatism / Ocular inflammation / Inflammatory bowel disease / flu / active inflammation / arthritis / rheumatic disease / Rheumatoid Arthritis / connective tissue diseases / Nephritis / Urethritis / Introduction Rheumatoid Arthritis / Infectious diarrhea / only inflammatory process / psoriasis / severe disease / Lupus / Psoriatic arthritis / RA Investigation Differentiate Inflammatory / Disease / iritis/uveitis / Rheumatic Diseases / chronic / dyslipidemia / cardiovascular disease / Osteoarthritis / pain / established disease / active disease / Osteoporosis / Reactive arthritis / infection / SLE / inflammation / Connective Tissue Disease / Inflammatory / / MedicalTreatment Immunizations / self-management / Antibiotics / biologic therapies / pain management / drug therapy / / Organization American College / / Person Ann Rheum Dis / / / Position VP / physician / specialist / Occupational Therapist / Governor / Physiotherapist / / Product acetaminophen / Sulfasalazine / prednisone / / ProgrammingLanguage Latex / / ProvinceOrState British Columbia / / Technology x-ray / antibodies / CVD / / URL www.bpac.org.nz / www.seniorsbc.ca / www.healthlinkbc.ca / www.arthritis.ca / www.bcguidelines.ca / www.rheuminfo.com / www.info.chardbc.ca / /
SocialTag |
Rheumatoid Arthritis: Diagnosis, Management and Monitoring Effective Date: September 30, 2012 Scope This guideline is intended to aid in early recognition, intervention and management of patients with rheumatoid